T1	Intervention 67 88	arzoxifene (LY353381)
T2	Intervention 251 289	estrogen receptor modulator arzoxifene
T3	Intervention 584 799	received arzoxifene 20 or 50 mg/day. Tumor response was assessed using World Health Organization criteria. Toxicities were graded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) system.